Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

Name: Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
Published: 2003
License: Public Domain

Alliance for Clinical Trials in Oncology · 2003

ClinicalTrials.gov · Datasets · License: Public Domain · 2003

Open Source ↗

leukemia

leukemia, myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms, refractory anemia with excess blasts, refractory anemia with ringed sideroblasts, refractory cytopenia with multilineage dysplasia, chronic myelomonocytic leukemia, de novo myelodysplastic syndromes, secondary myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasm, unclassifiable, refractory anemia, previously treated myelodysplastic syndromes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 828211
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.